Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Langtry

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Drugs|December 1, 1989
Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertensionH D Langtry, G J Mammen, E M Sorkin
Drugs|December 1, 1990
Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic useP A Todd, K L Goa, H D Langtry
Drugs|January 1, 1991
Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacyD W Harron, K L Goa, H D Langtry
Drugs|June 1, 1989
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseasesS M Grant, H D Langtry, R N Brogden
Drugs|January 1, 1993
Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseasesH A Friedel, H D Langtry, M M Buckley
Drugs|October 1, 1989
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseasesH D Langtry, S M Grant, K L Goa
Drugs|March 1, 1991
Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancerD Faulds, J A Balfour, P Chrisp, et al.
Drugs|January 1, 1993
Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmiasH M Bryson, K J Palmer, H D Langtry, et al.
Drugs|November 1, 1992
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potentialJ E Frampton, R N Brogden, H D Langtry, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Drugs|December 1, 1989
Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertensionH D Langtry, G J Mammen, E M Sorkin
Drugs|December 1, 1990
Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic useP A Todd, K L Goa, H D Langtry
Drugs|January 1, 1991
Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacyD W Harron, K L Goa, H D Langtry
Drugs|June 1, 1989
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseasesS M Grant, H D Langtry, R N Brogden
Drugs|January 1, 1993
Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseasesH A Friedel, H D Langtry, M M Buckley
Drugs|October 1, 1989
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseasesH D Langtry, S M Grant, K L Goa
Drugs|March 1, 1991
Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancerD Faulds, J A Balfour, P Chrisp, et al.
Drugs|January 1, 1993
Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmiasH M Bryson, K J Palmer, H D Langtry, et al.
Drugs|November 1, 1992
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potentialJ E Frampton, R N Brogden, H D Langtry, et al.
Pageof 3